NCT03855982View on ClinicalTrials.gov

Monitoring Drug-induced Myocarditis (CardiTOX)

CompletedOBSERVATIONAL
Enrollment

6,000

Participants

Timeline

Start Date

April 9, 2019

Primary Completion Date

February 25, 2020

Study Completion Date

April 4, 2023

Conditions
MyocarditisMyocardial FailureMyocardial Dysfunction
Interventions
DRUG

Drug inducing myocarditis

Drugs susceptible to induce myocarditis

Trial Locations (1)

75013

AP-HP, Pitié-Salpêtrière Hospital, Department of Pharmacology, CIC-1421, Pharmacovigilance Unit, INSERM, Paris

All Listed Sponsors
lead

Groupe Hospitalier Pitie-Salpetriere

OTHER

NCT03855982 - Monitoring Drug-induced Myocarditis (CardiTOX) | Biotech Hunter | Biotech Hunter